P4738New combined risk score to predict atrial fibrillation after cardiac surgery

Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 40; no. Supplement_1
Main Authors Burgos, L M, Gil Ramirez, A, Espinoza, J C, Seoane, L, Furmento, J F, Miranda, P R, Villalba, L, Cracco, M A, Polero, L D, Baro Vila, R, Berton, F, Navia, D, Benzadon, M N
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.10.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS. Methodology We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al. Results 3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%. Variables OR (CI 95%) P Age (years)   65–74 3.14 (2.29–4.31) <0.001   ≥75 8.68 (6.32–11.93) <0.001 Female sex 3.36 (2.68–4.22) <0.001 Heart failure 2.45 (1.82–3.31) <0.001 Stroke/TIA 2.33 (1.45–3.76) <0.001 Hypertension 1.68 (1.28–2.2) <0.001 Diabetes 1.72 (1.31–2.25) <0.001 Conclusion From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations.
AbstractList Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS. Methodology We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al. Results 3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%. Variables OR (CI 95%) P Age (years)   65–74 3.14 (2.29–4.31) <0.001   ≥75 8.68 (6.32–11.93) <0.001 Female sex 3.36 (2.68–4.22) <0.001 Heart failure 2.45 (1.82–3.31) <0.001 Stroke/TIA 2.33 (1.45–3.76) <0.001 Hypertension 1.68 (1.28–2.2) <0.001 Diabetes 1.72 (1.31–2.25) <0.001 Conclusion From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations.
Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and HATCH demonstrated a validated predictive to predict AF after CS (AFCS). Purpose To develop and validate a new risk score from the combination of the variables with highest predictive value of POAF, CHA2DS2-VASc and HATCH risk scores to predict AFCS. Methodology We conducted a single-center cohort study, performing a retrospective analysis of prospectively collected data. The study included consecutive patients undergoing CS between 2010–2016. The primary outcome was the development of new-onset AFCS during hospitalization. The variables of each score were evaluated in a multivariate regression model to determine the predictive impact. Discrimination was evaluated with area under the ROC curve (AUC-ROC) and calibration using the Hosmer-Lemeshow (HL) test. The Youden index was used to establish the best cut-off point for the score. The statistical difference between the ROC curves was evaluated with the method of DeLong et al. Results 3113 patients were included. Coronary artery bypass graft surgery 45%, valve replacement 24%, combined procedure (revascularization-valve surgery) 15%, and other procedures 16%. 21% (n=654) presented AFCS. Variables finally included in the new score were: age (≥75: 2, 65–74: 1), heart failure (2), female sex (1), hypertension (1), diabetes (1), previous stroke (1). The new score presented an AUC of 0.78 (95% CI 0.78–0.80), the rest of the scores presented lower discrimination ability (P<0.001): CHAD2DS2-VASc AUC 0.76, POAF 0.71 and HATCH 0.70. The HL test showed a p>0.05. For the new score, the best cut-off point was 2, with a sensitivity of 82% and specificity of 65.9%, presenting high negative predictive value: 92.9%. Variables OR (CI 95%) P Age (years)   65–74 3.14 (2.29–4.31) <0.001   ≥75 8.68 (6.32–11.93) <0.001 Female sex 3.36 (2.68–4.22) <0.001 Heart failure 2.45 (1.82–3.31) <0.001 Stroke/TIA 2.33 (1.45–3.76) <0.001 Hypertension 1.68 (1.28–2.2) <0.001 Diabetes 1.72 (1.31–2.25) <0.001 Conclusion From the combination of variables with higher predictive value included in the POAF, CHA2DS2-VASc, and HATCH scores, a new risk system was created to predict AFCS, presenting a greater predictive ability than the original ones. Being necessary future prospective validations.
Author Seoane, L
Espinoza, J C
Berton, F
Baro Vila, R
Villalba, L
Furmento, J F
Polero, L D
Burgos, L M
Gil Ramirez, A
Benzadon, M N
Cracco, M A
Navia, D
Miranda, P R
Author_xml – sequence: 1
  givenname: L M
  surname: Burgos
  fullname: Burgos, L M
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 2
  givenname: A
  surname: Gil Ramirez
  fullname: Gil Ramirez, A
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 3
  givenname: J C
  surname: Espinoza
  fullname: Espinoza, J C
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 4
  givenname: L
  surname: Seoane
  fullname: Seoane, L
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 5
  givenname: J F
  surname: Furmento
  fullname: Furmento, J F
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 6
  givenname: P R
  surname: Miranda
  fullname: Miranda, P R
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 7
  givenname: L
  surname: Villalba
  fullname: Villalba, L
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 8
  givenname: M A
  surname: Cracco
  fullname: Cracco, M A
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 9
  givenname: L D
  surname: Polero
  fullname: Polero, L D
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 10
  givenname: R
  surname: Baro Vila
  fullname: Baro Vila, R
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 11
  givenname: F
  surname: Berton
  fullname: Berton, F
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 12
  givenname: D
  surname: Navia
  fullname: Navia, D
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
– sequence: 13
  givenname: M N
  surname: Benzadon
  fullname: Benzadon, M N
  organization: Cardiovascular Institute of Buenos Aires (ICBA), Buenos Aires, Argentina
BookMark eNqNkNtqwkAURYdioWr7CYX5geiczCWTxyK9gfQCPvQtTOZSx8ZEzkSK_Xojlj4XDmw4sDabNSGjtms9IbfAZsBKPvd7XHuD_Wbu1z-FkDMAEBdkDDLPs1IJOSJjBqXMlNIfV2SS0oYxphWoMXl_EwXXL_6b2m5bx9Y7ijF90WQ79LTv6A69i7anpsdoGhpijbFpTB-7lprQe6TWoIvG0rTHT4-Ha3IZTJP8zW9OyerhfrV4ypavj8-Lu2VmdSEyHnJeQzmcA6shaF5KIYxSkikXIHcql7njUNfDjzM3rBXaWAclOJsXgU-JPNda7FJCH6odxq3BQwWsOmmp_rRUZy3VScvAsTPX7Xf_RI5TcGxP
ContentType Journal Article
Copyright Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019
Copyright_xml – notice: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com. 2019
DBID AAYXX
CITATION
DOI 10.1093/eurheartj/ehz745.1114
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate ESC Congress 2019 together with World Congress of Cardiology 31 August – 4 September 2019, Paris - France
EISSN 1522-9645
ExternalDocumentID 10_1093_eurheartj_ehz745_1114
10.1093/eurheartj/ehz745.1114
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29G
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
ABEUO
ABIXL
ABKDP
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
DAKXR
DIK
DILTD
D~K
E3Z
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
M49
MHKGH
ML0
N9A
NGC
NOMLY
NOYVH
NU-
O9-
OAUYM
OAWHX
OB3
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
ROZ
RUSNO
RW1
RXO
SEL
TCURE
TEORI
TJX
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
AAYXX
CITATION
ID FETCH-LOGICAL-c874-3f23b19b19d1c81f839544a66506df12d6252d31bba6630d86148acd191dc27f3
ISSN 0195-668X
IngestDate Thu Sep 12 18:57:11 EDT 2024
Wed Sep 11 04:51:50 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue Supplement_1
Keywords Cardiovascular Surgery - Arrhythmias
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c874-3f23b19b19d1c81f839544a66506df12d6252d31bba6630d86148acd191dc27f3
ParticipantIDs crossref_primary_10_1093_eurheartj_ehz745_1114
oup_primary_10_1093_eurheartj_ehz745_1114
PublicationCentury 2000
PublicationDate 20191001
2019-10-01
PublicationDateYYYYMMDD 2019-10-01
PublicationDate_xml – month: 10
  year: 2019
  text: 20191001
  day: 01
PublicationDecade 2010
PublicationTitle European heart journal
PublicationYear 2019
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0008616
Score 2.348281
Snippet Abstract Introduction Atrial fibrillation after cardiac surgery (AFCS) is associated with an increase in adverse events. The scores POAF, CHA2DS2-VASc and...
SourceID crossref
oup
SourceType Aggregation Database
Publisher
Title P4738New combined risk score to predict atrial fibrillation after cardiac surgery
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxtBEF-qBfGl1FbRqmUf-iLhonu79_UoJUaKKSop5O2429vViCYhOV_y1zuzu_eRGooWwnEsYbi7-TE7M_ubGUJ-aImTT7LEEzI-80QktZdpVnia8wiPcVSYYUJ_8Du8_CN-jYJRc1xgqkvKvCuXa-tK_kersAZ6xSrZd2i2FgoLcA_6hStoGK5v0vG1iLiZpQPCIcJVjim-wNaU6FTO5ngMgwWLZjaHRnr_oyW_ueHg0gBEdhavq6PrPD3OvC477Qey5Q93lqF31SRU--PHzm32BFZ0uZIm7S1m48l0aWm5rbysmjqm7VU7-cCSmsZW5yOTwAtDMx0YthNnQyG-TULbJbIysrYnkwOTGVhqsp8pW2vGbYsr9Tw3b_iA9_fLSARo4EWzc1Wn9X9taDXN0B6w87QWlFoxGPaIDfLRB-OENMD-qKEFxaEZl1u_WFX1lfDTWsxp62lW_BmskWy5J8PP5JOLK-i5BckO-aAmX8jWwDEnvpKbCiu0wgpFrFCDFVpOqcMKtVihbaxQgxXqsEIdVnbJ8KI3_HnpuXEanowj4XHt85wl8CuYjJkGzzgQIgvBRQ8LzfwCImG_4CzPYY2fFTG2iM1kAQF9If1I8z2yOZlO1D6hOK46kj6EokwKkcdZkCdBHPmKsSQWmTog3eqbpDPbNCX9py4OyAl8ubf999t7hR-S7Qa6R2SznD-rY_Aky_y7Uf0LJoZ2Hw
link.rule.ids 315,783,787,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P4738New+combined+risk+score+to+predict+atrial+fibrillation+after+cardiac+surgery&rft.jtitle=European+heart+journal&rft.au=Burgos%2C+L+M&rft.au=Gil+Ramirez%2C+A&rft.au=Espinoza%2C+J+C&rft.au=Seoane%2C+L&rft.date=2019-10-01&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=40&rft.issue=Supplement_1&rft_id=info:doi/10.1093%2Feurheartj%2Fehz745.1114&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_eurheartj_ehz745_1114
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon